Dogwood Therapeutics, Inc.
NASDAQ:DWTXBiotechnology
+$0.04 today
- Market cap
- $51.12M
- Beta
- 1.76
- P/E (TTM)
- -0.2
- EPS (TTM)
- -$0.84
Volume 0.12M
Average 0.09M
Balance Sheet
Inspect the capital base behind the business.
Assets
$90.17M
FY 2025 · Annual
-4.4% YoYLiabilities
$15.27M
FY 2025 · Annual
-49.1% YoYEquity
$74.90M
FY 2025 · Annual
+16.5% YoYBalance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 14.01M | 7.03M | 3.32M | 14.85M | 6.52M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 863 | 7.29K | 3.56K | 28.01K | 4.88K |
| Total Current Assets | 15.78M | 8.37M | 4.17M | 16.54M | 8.43M |
| Property, Plant & Equipment (Net) | 0 | 0 | 0 | 222.65K | 194.93K |
| Goodwill | 0 | 0 | 0 | 11.81M | 12.4M |
| Intangible Assets | 0 | 0 | 0 | 65.71M | 68.99M |
| Long-term Investments | 0 | 0 | 0 | 18.13K | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 0 | 0 | 0 | 0 | 158.96K |
| Total Non-current Assets | 0 | 0 | 0 | 77.76M | 81.74M |
| Total Assets | 15.78M | 8.37M | 4.17M | 94.31M | 90.17M |
| Account Payables | 353.86K | 573.16K | 111.91K | 1.23M | 760.95K |
| Short-term Debt | 0 | 0 | 0 | 49.7K | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 532.68K | 159.7K | 0 | 687.59K | 745.08K |
| Total Current Liabilities | 1.28M | 1.04M | 358.55K | 3.18M | 3.06M |
| Long-term Debt | 0 | 0 | 0 | 15.38M | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 11.31M | 12.11M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Non-current Liabilities | 0 | 0 | 0 | 26.85M | 12.22M |
| Total Liabilities | 1.28M | 1.04M | 358.55K | 30.03M | 15.27M |
| Common Stock | 833 | 1.83K | 77 | 133 | 2.97K |
| Retained Earnings | (43.93M) | (56.17M) | (61.47M) | (73.82M) | (108.08M) |
| Accumulated OCI | 0 | 0 | 0 | (3.86M) | (587.04K) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 14.5M | 7.33M | 3.81M | 64.28M | 74.9M |
| Total Debt | 0 | 0 | 0 | 15.59M | 162.6K |
| Net Debt | (14.01M) | (7.03M) | (3.32M) | 737.71K | (6.36M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $13.2M |
| Other Current | $1.8M |
| Total Current Assets | $15.0M |
| PP&E (Net) | $159.3K |
| Goodwill | $12.2M |
| Intangible Assets | $67.8M |
| Other Non-current | $18.7K |
| Total Non-current Assets | $80.2M |
| Total Assets | $95.2M |
Analysis
Selected assets total $95.2M for Latest. The largest visible component is Intangible Assets at $67.8M, about 71.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 7, 2025 | |
| 8-K | Current report | Nov 6, 2025 | |
| DEF 14A | DEF 14A filing | Oct 20, 2025 | |
| S-3/A | S-3/A filing | Oct 16, 2025 | |
| DEFA14A | DEFA14A filing | Oct 9, 2025 |
How much cash does DWTX have?
Dogwood Therapeutics, Inc. (DWTX) reported $6.52M in cash and equivalents in fiscal 2025.
How much debt does DWTX carry?
Dogwood Therapeutics, Inc. (DWTX) reported $162,604.00 of total debt, with net debt of -$6.36M.
Continue the stock analysis
Jump to another research area for this company.